Angina: Clinical Trials

11 trials for Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 2 withdrawn, 1 recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Unknown 4, Completed 3, Withdrawn 2, Recruiting 1, Terminated 1

Follow Angina: new trials by email Literature Review of Angina trials Research Report on Angina

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
Clinician Discretion, Beta blocker, Calcium channel blocker - Angina, Stable Ischemic Heart Disease
Phase 4RecruitingYale University7412023-05-102026-04-07
Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR)
Ranolazine, Placebo - Angina
Phase 4UnknownAmit Malhotra, MD402017-01-102017-02-07
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
Topical Nitroglycerine, Topical Lidocaine - Radial Artery Spasm, Angina
Phase 4CompletedAultman Health Foundation1002016-09-012020-10-27
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
Ivabradine - Coronary Artery Disease, Angina
Phase 4WithdrawnLiverpool Heart and Chest Hospital NHS Foundation Trust2016-03-012018-08-17
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
Salvianolate injection, Aspirin - Angina
Phase 4UnknownChina Academy of Chinese Medical Sciences1202016-02-012016-03-01
Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
Pitavastatin 1mg, Pitavastatin 4mg, Placebo - Atherosclerosis, Neointima
Phase 4CompletedKorea University Anam Hospital10002013-02-012020-11-10
Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
Esmolol, Metoprolol - Vascular Disease, Hypertension
Phase 4TerminatedUniversity Health Network, Toronto202011-04-012015-04-21
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine - Coronary Artery Disease, Angina
Phase 4UnknownAtlanta Heart Specialists, LLC1602011-01-012013-07-11
Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
Ivabradine, Carvedilol - Coronary Heart Disease, Angina
Phase 4UnknownUniversity of Campania Luigi Vanvitelli2202011-01-012012-06-28
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
Ranolazine, Placebo - Peripheral Arterial Disease, Angina
Phase 4WithdrawnColorado Prevention Center2008-05-012014-08-15
Double Blind Atorvastatin Amlodipine Study
amlodipine, atorvastatin - Angina
Phase 4CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.3602001-07-012021-01-28

Narrower conditions

Angina Pectoris (11)  ·  Coronary Artery Disease (3)  ·  Atherosclerosis (1)  ·  Chest Pain (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Neointima (1)  ·  Peripheral Arterial Disease (1)  ·  Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (11)  ·  Myocardial Ischemia (11)  ·  Neurologic Manifestations (11)  ·  Pain (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (11)  ·  Chest Pain (10)  ·  Heart Diseases (10)  ·  Vascular Diseases (10)  ·  Arterial Occlusive Diseases (5)  ·  Arteriosclerosis (5)  ·  Coronary Disease (3)  ·  Atherosclerosis (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)

Interventions

Ranolazine (3)  ·  Ivabradine (2)  ·  Adrenergic beta-Antagonists (1)  ·  Amlodipine (1)  ·  Anesthetics, Local (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Calcium Channel Blockers (1)  ·  Carvedilol (1)  ·  Lidocaine (1)  ·  Metoprolol (1)  ·  Nitroglycerin (1)  ·  Vasodilation (1)  ·  esmolol (1)  ·  pitavastatin (1)

Sponsors

Amit Malhotra, MD (1)  ·  Atlanta Heart Specialists, LLC (1)  ·  Aultman Health Foundation (1)  ·  China Academy of Chinese Medical Sciences (1)  ·  Colorado Prevention Center (1)  ·  Korea University Anam Hospital (1)  ·  Liverpool Heart and Chest Hospital NHS Foundation Trust (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  University Health Network, Toronto (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  Yale University (1)

Countries

United States (5)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Latvia (1)  ·  Norway (1)  ·  Poland (1)  ·  Romania (1)  ·  Slovakia (1)  ·  South Africa (1)  ·  South Korea (1)

Top investigators

Aleem Khand, MBChB MD (1)  ·  Amit Malhotra, MD (1)  ·  Do-Sun Lim, MD, PhD (1)  ·  Gennaro Cice, MD (1)  ·  Mark R Nehler, MD (1)  ·  Michael Nanna, MD (1)  ·  Narendra Singh, MD (1)  ·  Prabhakaran Gopalakrishnan, MD (1)  ·  Scott Beattie, MD, FRCP (1)  ·  William R Hiatt, MD (1)  ·  Yanming Xie, Study Chair (1)

Results publications

PMID 20494902, PMID 30047013, PMID 31752850, PMID 33360345

NIH funding

K76AG088428 (1)